Cargando…

Ikaros Regulates microRNA Networks in Acute Lymphoblastic Leukemia

The hematopoietic transcription factor Ikaros (IKZF1) regulates normal B cell development and functions as a tumor suppressor in precursor B cell acute lymphoblastic leukemia (B-ALL). MicroRNAs (miRNAs) are small regulatory RNAs that through post-transcriptional gene regulation play critical roles i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kogut, Sophie, Paculova, Hana, Rodriguez, Princess, Boyd, Joseph, Richman, Alyssa, Palaria, Amrita, Schjerven, Hilde, Frietze, Seth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624360/
https://www.ncbi.nlm.nih.gov/pubmed/36278683
http://dx.doi.org/10.3390/epigenomes6040037
_version_ 1784822218239246336
author Kogut, Sophie
Paculova, Hana
Rodriguez, Princess
Boyd, Joseph
Richman, Alyssa
Palaria, Amrita
Schjerven, Hilde
Frietze, Seth
author_facet Kogut, Sophie
Paculova, Hana
Rodriguez, Princess
Boyd, Joseph
Richman, Alyssa
Palaria, Amrita
Schjerven, Hilde
Frietze, Seth
author_sort Kogut, Sophie
collection PubMed
description The hematopoietic transcription factor Ikaros (IKZF1) regulates normal B cell development and functions as a tumor suppressor in precursor B cell acute lymphoblastic leukemia (B-ALL). MicroRNAs (miRNAs) are small regulatory RNAs that through post-transcriptional gene regulation play critical roles in intracellular processes including cell growth in cancer. However, the role of Ikaros in the regulation of miRNA expression in developing B cells is unknown. In this study, we examined the Ikaros-regulated miRNA targets using human IKZF1-mutated Ph(+) B-ALL cell lines. Inducible expression of wild-type Ikaros (the Ik1 isoform) caused B-ALL growth arrest and exit from the cell cycle. Global miRNA expression analysis revealed a total of 31 miRNAs regulated by IK1, and ChIP-seq analysis showed that Ikaros bound to several Ik1-responsive miRNA genes. Examination of the prognostic significance of miRNA expression in B-ALL indicate that the IK1-regulated miRNAs hsa-miR-26b, hsa-miR-130b and hsa-miR-4649 are significantly associated with outcome in B-ALL. Our findings establish a potential regulatory circuit between the tumor-suppressor Ikaros and the oncogenic miRNA networks in IKZF1-mutated B-ALL. These results indicate that Ikaros regulates the expression of a subset of miRNAs, of which several may contribute to B-ALL growth.
format Online
Article
Text
id pubmed-9624360
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96243602022-11-02 Ikaros Regulates microRNA Networks in Acute Lymphoblastic Leukemia Kogut, Sophie Paculova, Hana Rodriguez, Princess Boyd, Joseph Richman, Alyssa Palaria, Amrita Schjerven, Hilde Frietze, Seth Epigenomes Article The hematopoietic transcription factor Ikaros (IKZF1) regulates normal B cell development and functions as a tumor suppressor in precursor B cell acute lymphoblastic leukemia (B-ALL). MicroRNAs (miRNAs) are small regulatory RNAs that through post-transcriptional gene regulation play critical roles in intracellular processes including cell growth in cancer. However, the role of Ikaros in the regulation of miRNA expression in developing B cells is unknown. In this study, we examined the Ikaros-regulated miRNA targets using human IKZF1-mutated Ph(+) B-ALL cell lines. Inducible expression of wild-type Ikaros (the Ik1 isoform) caused B-ALL growth arrest and exit from the cell cycle. Global miRNA expression analysis revealed a total of 31 miRNAs regulated by IK1, and ChIP-seq analysis showed that Ikaros bound to several Ik1-responsive miRNA genes. Examination of the prognostic significance of miRNA expression in B-ALL indicate that the IK1-regulated miRNAs hsa-miR-26b, hsa-miR-130b and hsa-miR-4649 are significantly associated with outcome in B-ALL. Our findings establish a potential regulatory circuit between the tumor-suppressor Ikaros and the oncogenic miRNA networks in IKZF1-mutated B-ALL. These results indicate that Ikaros regulates the expression of a subset of miRNAs, of which several may contribute to B-ALL growth. MDPI 2022-10-19 /pmc/articles/PMC9624360/ /pubmed/36278683 http://dx.doi.org/10.3390/epigenomes6040037 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kogut, Sophie
Paculova, Hana
Rodriguez, Princess
Boyd, Joseph
Richman, Alyssa
Palaria, Amrita
Schjerven, Hilde
Frietze, Seth
Ikaros Regulates microRNA Networks in Acute Lymphoblastic Leukemia
title Ikaros Regulates microRNA Networks in Acute Lymphoblastic Leukemia
title_full Ikaros Regulates microRNA Networks in Acute Lymphoblastic Leukemia
title_fullStr Ikaros Regulates microRNA Networks in Acute Lymphoblastic Leukemia
title_full_unstemmed Ikaros Regulates microRNA Networks in Acute Lymphoblastic Leukemia
title_short Ikaros Regulates microRNA Networks in Acute Lymphoblastic Leukemia
title_sort ikaros regulates microrna networks in acute lymphoblastic leukemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624360/
https://www.ncbi.nlm.nih.gov/pubmed/36278683
http://dx.doi.org/10.3390/epigenomes6040037
work_keys_str_mv AT kogutsophie ikarosregulatesmicrornanetworksinacutelymphoblasticleukemia
AT paculovahana ikarosregulatesmicrornanetworksinacutelymphoblasticleukemia
AT rodriguezprincess ikarosregulatesmicrornanetworksinacutelymphoblasticleukemia
AT boydjoseph ikarosregulatesmicrornanetworksinacutelymphoblasticleukemia
AT richmanalyssa ikarosregulatesmicrornanetworksinacutelymphoblasticleukemia
AT palariaamrita ikarosregulatesmicrornanetworksinacutelymphoblasticleukemia
AT schjervenhilde ikarosregulatesmicrornanetworksinacutelymphoblasticleukemia
AT frietzeseth ikarosregulatesmicrornanetworksinacutelymphoblasticleukemia